Susquehanna International Group’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-23,655
| Closed | -$464K | – | 14155 |
|
|
2025
Q4 | $464K | Buy |
+23,655
| New | +$491K | ﹤0.01% | 8964 |
|
|
2025
Q3 | – | Sell |
-20,952
| Closed | -$640K | – | 13970 |
|
|
2025
Q2 | $640K | Sell |
20,952
-4,449
| -18% | -$126K | ﹤0.01% | 8598 |
|
|
2025
Q1 | $685K | Buy |
25,401
+18,457
| +266% | +$584K | ﹤0.01% | 8194 |
|
|
2024
Q4 | $249K | Buy |
+6,944
| New | +$260K | ﹤0.01% | 10217 |
|
|
2024
Q1 | – | Sell |
-3,843
| Closed | -$206K | – | 13399 |
|
|
2023
Q4 | $206K | Buy |
+3,843
| New | +$194K | ﹤0.01% | 10621 |
|
|
2023
Q3 | – | Sell |
-5,434
| Closed | -$343K | – | 13049 |
|
|
2023
Q2 | $343K | Sell |
5,434
-3,130
| -37% | -$199K | ﹤0.01% | 9172 |
|
|
2023
Q1 | $539K | Buy |
+8,564
| New | +$511K | ﹤0.01% | 8400 |
|
|
2022
Q4 | – | Sell |
-6,985
| Closed | -$392K | – | 13743 |
|
|
2022
Q3 | $392K | Buy |
6,985
+233
| +3% | +$15.4K | ﹤0.01% | 9110 |
|
|
2022
Q2 | $489K | Buy |
+6,752
| New | +$503K | ﹤0.01% | 8318 |
|
|
2022
Q1 | – | Sell |
-6,000
| Closed | -$607K | – | 14030 |
|
|
2021
Q4 | $607K | Buy |
+6,000
| New | +$599K | ﹤0.01% | 8646 |
|
|
2021
Q2 | – | Sell |
-6,867
| Closed | -$689K | – | 13297 |
|
|
2021
Q1 | $670K | Buy |
6,867
+2,441
| +55% | +$222K | ﹤0.01% | 8775 |
|
|
2020
Q4 | $341K | Buy |
+4,426
| New | +$342K | ﹤0.01% | 9022 |
|
|
2020
Q3 | – | Sell |
-8,305
| Closed | -$666K | – | 11192 |
|
|
2020
Q2 | $610K | Sell |
8,305
-41,634
| -83% | -$3.27M | ﹤0.01% | 6947 |
|
|
2020
Q1 | $2.88M | Buy |
+49,939
| New | +$3.47M | ﹤0.01% | 3349 |
|
|
2019
Q4 | – | Sell |
-8,676
| Closed | -$639K | – | 10699 |
|
|
2019
Q3 | $593K | Sell |
8,676
-387
| -4% | -$26K | ﹤0.01% | 6910 |
|
|
2019
Q2 | $720K | Buy |
+9,063
| New | +$719K | ﹤0.01% | 6443 |
|
|
2017
Q1 | – | Sell |
-15,864
| Closed | -$971K | – | 10021 |
|
|
2016
Q4 | $971K | Buy |
+15,864
| New | +$1.03M | ﹤0.01% | 5595 |
|
|
2015
Q4 | – | Sell |
-68,200
| Closed | -$4.57M | – | 10019 |
|
|
2015
Q3 | $4.57M | Sell |
68,200
-14,000
| -17% | -$990K | ﹤0.01% | 2798 |
|
|
2015
Q2 | $5.62M | Hold |
82,200
| – | – | ﹤0.01% | 2734 |
|
|
2015
Q1 | $4.57M | Sell |
82,200
-53,054
| -39% | -$2.72M | ﹤0.01% | 2870 |
|
|
2014
Q4 | $6.94M | Buy |
135,254
+73,076
| +118% | +$3.59M | ﹤0.01% | 2428 |
|
|
2014
Q3 | $2.29M | Buy |
62,178
+56,972
| +1,094% | +$2.06M | ﹤0.01% | 4362 |
|
|
2014
Q2 | $203K | Buy |
+5,206
| New | +$193K | ﹤0.01% | 9040 |
|
|
2013
Q4 | – | Sell |
-9,448
| Closed | -$410K | – | 9364 |
|
|
2013
Q3 | $410K | Buy |
+9,448
| New | +$379K | ﹤0.01% | 6739 |
|
Other funds holding USNA
NCM
VCM
VPM
Susquehanna International Group's USNA Position: Q1 2026 in Review
Susquehanna International Group sold out of Usana Health Sciences (USNA) in Q1 2026, closing a stake of 23,655 shares — an estimated $464K sold.
Susquehanna International Group first reported a position in USNA in Q3 2013 and held it in 24 quarters. The position peaked at $6.94M in Q4 2014. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Susquehanna International Group reported no remaining Usana Health Sciences position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 23,655 Usana Health Sciences shares in Q1 2026, an estimated $464K.
- Susquehanna International Group first reported a position in Usana Health Sciences in Q3 2013 and held it in 24 quarters.
- Susquehanna International Group's Usana Health Sciences position peaked at $6.94M in Q4 2014.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.